CPRX - Catalyst Pharmaceuticals stock plummets on 10M share Spot Secondary priced at $15
2024-01-05 08:23:53 ET
More on Catalyst Pharmaceuticals
- Catalyst Pharmaceuticals, Inc. (CPRX) Q3 2023 Earnings Call Transcript
- Catalyst Pharmaceuticals: Agamree Approval Selloff A Long-Term Buying Opportunity
- Catalyst Pharmaceuticals stock sinks on proposed public offering of common stock
- Catalyst Pharmaceuticals appoints Kalb as its CFO
- Seeking Alpha’s Quant Rating on Catalyst Pharmaceuticals
For further details see:
Catalyst Pharmaceuticals stock plummets on 10M share Spot Secondary priced at $15